Refresh

Beta Drugs Ltd. - Research Center

Group () BSE data
Back to Company

Results

Statement

More

Profit & Loss Account
(Rs crore)
Mar ' 23 Mar ' 22 Mar ' 21 Mar ' 20 Mar ' 19
Income

Operating income

157.87 124.85 79.46 65.32 58.05
Expenses

Material consumed

85.62 72.50 44.38 35.33 31.76

Manufacturing expenses

13.04 10.35 8.48 7.29 6.06

Personnel expenses

13.42 8.72 6.06 4.93 3.42

Selling expenses

0.03 0.06 - 0.05 0.09

Adminstrative expenses

14.57 8.03 5.23 5.97 6.42

Expenses capitalised

- - - - -

Cost of sales

126.68 99.66 64.15 53.57 47.74

Operating profit

31.20 25.18 15.31 11.75 10.31

Other recurring income

1.04 0.86 0.61 0.42 0.32

Adjusted PBDIT

32.24 26.04 15.92 12.17 10.62

Financial expenses

0.84 0.41 0.77 0.64 0.73

Depreciation

6.19 5.47 5.27 2.58 2.42

Other write offs

- - - - -

Adjusted PBT

25.21 20.16 9.88 8.95 7.47

Tax charges

6.39 5.92 2.90 1.85 -0.25

Adjusted PAT

18.82 14.25 6.98 7.10 7.71

Non recurring items

- - - - -

Other non cash adjustments

- - - - -

Reported net profit

18.82 14.25 6.98 7.10 7.71

Earnigs before appropriation

62.72 44.11 29.86 22.89 15.79

Equity dividend

- - - - -

Preference dividend

- - - - -

Dividend tax

- - - - -

Retained earnings

62.72 44.11 29.86 22.89 15.79
Sectoral Indices Market Indicators Listed Companies Gainers Losers Mutual Funds Portfolio Watchlist
© 2024 Rediff.com